Erin E. Gabriel

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria

Major challenges and barriers in clinical decision-making as perceived by emergency medical services personnel: a qualitative content analysis

European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators

Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Adenoviral vectors coated with cationic PEG derivatives for intravaginal vaccination against HIV-1

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

Current approaches to malaria vaccines

Changes in Neuron-Specific Enolase are More Suitable Than Its Absolute Serum Levels for the Prediction of Neurologic Outcome in Hypothermia-Treated Patients with Out-of-Hospital Cardiac Arrest

European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: Automated external defibrillators, defibrillation, cardioversion and pacing

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Vaccine innovations for emerging infectious diseases—a symposium report

Immune correlates of vaccine protection against HIV-1 acquisition

Review Paper: Emergency Medical Technicians’ Ethical Challenges in the Prehospital Emergency Services: A Review Article

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

Part 8: Post–Cardiac Arrest Care

Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization

Predictors of Survival From Out-of-Hospital Cardiac Arrest

Survival Increases with CPR by Emergency Medical Services before defibrillation of out-of-hospital ventricular fibrillation or ventricular tachycardia: Observations from the Resuscitation Outcomes Consortium

Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve